The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis
Masahiro Okada +8 more
openalex +2 more sources
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial [PDF]
Peter Saunders +10 more
openalex +1 more source
Immunosuppression and Surgery‐Free Interval in Granulomatosis With Polyangiitis Airway Stenosis
Subglottic and tracheal stenosis are severe manifestations of granulomatosis with polyangiitis (GPA) that often require both endoscopic intervention and systemic immunosuppression. Rituximab may help stabilize GPA‐related airway disease by prolonging the interval between endoscopic procedures and delaying relapse.
Sydney J. Torres +6 more
wiley +1 more source
Low serum albumin levels and the nongerminal center B-cell subtype according to the Hans algorithm as strong prognostic factors in ≥ 80-year-old patients with large B-cell lymphoma treated with rituximab-containing chemotherapy. [PDF]
Kawashima I +13 more
europepmc +1 more source
Long‐term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial [PDF]
Dai Chihara +14 more
openalex +1 more source
A Case of Palmoplantar Vesiculobullous Lesions
JEADV Clinical Practice, EarlyView.
Ali Abid +3 more
wiley +1 more source
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments. [PDF]
Bilodeau PA +11 more
europepmc +1 more source
Polymorphic Mucocutaneous Eruption and Septic Shock in a 75‐Year‐Old Man
JEADV Clinical Practice, EarlyView.
Sweta Subhadarshani +2 more
wiley +1 more source
Case Report: Relapsing systemic lupus erythematosus treated with dual rituximab and anifrolumab therapy. [PDF]
Lee S, Choi J, Benitez S, Lee J.
europepmc +1 more source

